Research Paper Volume 16, Issue 5 pp 4423—4444
SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma
Figure 2. HNSCC prognosis via SLC20A1. (A) Kaplan-Meier analysis of poor survival outcomes with SLC20A1 overexpression in HNSCC from TCGA database. (B) Risk score with survival time in TCGA database. (C, D) Forest plots representing the uni- and multivariate analysis of the significantly marked prognostics.